TP53 germline mutations in the context of families with hereditary breast and ovarian cancer: a clinical challenge
Sabine Grill(TUM Klinikum), Anne S. Quante(Helmholtz Munich), Eva Groß(TUM Klinikum), Nina Ditsch(Ludwig-Maximilians-Universität München), Christine Brambs(Technical University of Munich), Nicole Pfarr(Technical University of Munich), Heide Hellebrand(Ludwig-Maximilians-Universität München), Marion Kiechle(Klinikum rechts der Isar), Juliane Ramser(Klinikum rechts der Isar), Melanie Boxberg(Starnberg Hospital), Alfons Meindl(Helmholtz Zentrum München), Thomas Meitinger(Helmholtz Zentrum München)
Cited by 8
Related Papers
The DNA sequence of the human X chromosome
|Nature|2005|1.2k
A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets
|Nature Genetics|1995|1.1k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k
Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia
|Nature Neuroscience|2015|782